0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Viewpoint |

Do It Yourself Newborn Screening

Pascal Borry, PhD1; Karine Sénécal, LLM2; Bartha Maria Knoppers, PhD2
[+] Author Affiliations
1Centre for Biomedical Ethics and Law, Department of Public Health and Primary Care, University of Leuven, Kapucijnenvoer, Leuven, Belgium
2Centre of Genomics and Policy, Department of Human Genetics, McGill University, Montreal, Quebec, Canada
JAMA Pediatr. 2016;170(6):523-524. doi:10.1001/jamapediatrics.2016.0166.
Text Size: A A A
Published online

Extract

This Viewpoint discourages the use of commercial newborn screening kits that are marketed to parents and calls for regulation.

Direct-to-consumer (DTC) genetic testing on the Internet is flourishing and now includes disease risk testing that complements health care. Direct-to-consumer genetic testing continues to raise concerns, notably about consent and counseling issues, in addition to the clinical validity and utility of the tests. Direct-to-consumer genetic testing in children adds specific issues.1 Clinical guidelines currently advocate that testing and screening minors is only recommended when established, effective, and important medical treatment can be offered or when testing provides scope for treatment that may prevent, defer, or alleviate the outbreak of disease or its consequences. This reflects the careful consideration that is usually given to genetic tests, for which special attention is paid to communication about the test and its results, the confidentiality of genetic information, the willingness of the client to make the request, and the psychosocial impact of the test results. Recently, a new form of DTC genetic tests for children has emerged that raises additional ethical issues: a supplemental newborn screening (NBS) test sold to expecting couples. Although a few companies already sell such tests, the Baby Genes service is novel in several respects (https://www.babygenes.net).

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment
Education and Advancement of Newborn Screening
Posted on May 2, 2016
Max Truesdel
Baby Genes, Inc.
Conflict of Interest: Baby Genes, Inc. is a privately held company based in Golden, Colorado focused on advancing newborn screening and education.
A point of clarification from Baby Genes, Inc.

https://www.babygenes.net/2016/04/baby-genes-inc-overview-and-applications/
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

797 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs
brightcove.createExperiences();